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Cisplatin (cisPt) is a chemotherapy agent used as a treatment for several types of cancer. The main cytotoxic eﬀect of cisplatin
is generally accepted to be DNA damage. Recently, the mechanism by which cisPt generates the cascade of events involved in the
apoptotic process has been demonstrated. In particular it has been shown that some organelles are cisPt target and are involved
in cell death. This paper aims to describe the morphological and functional changes of the Golgi apparatus and lysosomes during
apoptosis induced in neuronal rat cells (B50) by cisplatin. The results obtained show that the cellular organelles are the target of
cisPt, so their damage can induce cell death.
1.Introduction
Frommanyyears,cisplatin(cisPt)wasusedinchemotherapy
of diﬀerent cancers because of its apoptotic eﬀects. It
binds DNA-generating adduct cisPt/DNA that provokes the
distortion of double helix blocking the transcription and
the replication processes [1]. We reported that, in B50
neuroblastoma rat cells, cisPt induces cytotoxic cell death
mediated by activation of death receptor-mediated apoptotic
signaling mechanisms as well as mitochondrial pathways
[2,3].Nevertheless,organellesdamagecisPtinducedistoday
not so well elucidated. The cytotoxic action of this drug can
beinitiatedbycytoplasmiceventsthusdeterminingorganelle
damage. Yu et al. [4] demonstrated, in fact, that cisplatin
initiates apoptosis from the cytoplasm and suggested that
nuclear events may not be critical for the initiation of
cisplatin-induced cytotoxicity, at least, not in immortalized
mouse kidney proximal tubule epithelial (TKPTS) cells [4].
Apoptosis is a genetically controlled cell death program
consisting of several essential steps that are critical check-
points, as well as nonessential steps depending on the cell
type, context, or pathophysiological stimuli [5]. Moreover,
the intricate network of relationships and communication
(i.e., crosstalk in which multiple organelles emit signals and
receive responses) occurs between all the cellular organelles.
During apoptosis, the cytoskeleton undergoes disassembly,
bringing with him the diﬀerent organelles, such as the Golgi
vesicles, which in apoptosis following the reorganization of
microtubules[6–8]wastingaclearspatialorganizationinthe
cell [9, 10]. Mitochondria and endoplasmic reticulum are,
respectively, involved in intrinsic apoptotic pathway and in
the pathway mediated by caspase 12 [11].
We have demonstrated that in B50 neuronal rat cells
cisplatin induces apoptosis, morphological and functional
modiﬁcation of cytoskeleton, mitochondria [12], and endo-
plasmic reticulum [2], yet. In this work we applied histo-
chemical techniques in confocal microscopy and electron
microscopytotheanalysesofchangesofGolgiapparatusand
lysosomes in B50 cells after treatment with cisPt.
2.MaterialandMethods
2.1. Cells and Treatments. B50 neuroblastoma rat cells
(Istituto Zooproﬁlattico Sperimentale della Lombardia e
dell’Emilia Romagna, cat. n. BS TCL 115) were cultured in2 International Journal of Cell Biology
“75cm2”ﬂasksinDulbecco’sminimalessentialmediumsup-
plemented with “10%” fetal bovine serum, “1%” glutamine,
“100U”penicillin,andstreptomycin(Celbio)ina“5%CO2”
humidiﬁed atmosphere. “24h” before experiments, cells
were seeded on glass coverslips for ﬂuorescence microscopy,
or grown in “75cm2” plastic ﬂasks for electron microscopy
analysis.
Cells are submitted to a continued exposure to cisPt
(TevaPharma)“40μM”for“48h”at“37◦C”.Thisconcentra-
tion was chosen considering our in vivo experimental design
(i.e., a single injection of “5μg/g” b. w. in “10-day-old” rats);
this dose corresponds to the dose most commonly used in
chemotherapy [13, 14]. For immunocytochemical analysis,
after the treatments, the samples grown on coverslips were
ﬁxed with “4%” formalin and postﬁxed with “70%” ethanol
for “30min” each, at “−20◦C.”
2.2. Double Immunocytochemical Detection of Golgi Proteins
and Cytoskeletal Components. Cells were incubated with a
solution of anti-Golgi proteins (autoimmune serum rec-
ognizing the Golgi proteins, a kind gift of the IRCCS
San Matteo, Pavia, Italy) diluted “1:400” in PBS and
another primary antibody: Alexa 594-Phalloidin (Molecular
Probes, Invitrogen) diluted “1:40” in PBS. After “60min”
at room temperature, coverslips were incubated with the
secondary antibody: Alexa 488-conjugated anti-human anti-
body (Molecular Probes, Invitrogen) diluted “1:200” in PBS
for Golgi protein for “1h.” Sections were counterstained for
DNA with “0.1μg/mL” Hoechst “33258,” washed with PBS,
and mounted in a drop of Mowiol (Calbiochem), for con-
focal microscopy analysis. Three independent experiments
were carried out.
2.3. Double Immunocytochemical Detection of Golgi Proteins
and Endoplasmic Reticulum. Cells were incubated with a
solution of anti-Golgi proteins (autoimmune serum recog-
nizing the Golgi proteins, a kind gift of the IRCCS San
Matteo, Pavia, Italy) diluted “1:400” in PBS and another
primary antibody: antireticulum proteins (Abcam) diluted
“1:100” in PBS. After “60min” at room temperature, cov-
erslips were incubated with the secondary antibodies: Alexa
488-conjugated anti-human antibody (Molecular Probes,
Invitrogen) diluted “1:200” in PBS for Golgi protein and
Alexa-594-coniugated anti-rabbit antibody for reticulum
proteins for “1h.” Sections were counterstained for DNA
with “0.1μg/mL” Hoechst “33258,” washed with PBS and
mounted in a drop of Mowiol (Calbiochem), for confocal
microscopy analysis. Three independent experiments were
carried out.
2.4. Golgi Apparatus and Endoplasmic Reticulum Morpho-
logical Features at Transmission Electron Microscopy (TEM).
For TEM analysis, the cells grown in “75cm2” plastic
ﬂasks for electron microscopy harvested by mild trypsiniza-
tion (“0.25%” trypsin in PBS containing “0.05%” EDTA),
immediately ﬁxed with “2%” glutaraldehyde in the culture
medium (“1h” at “4◦C”) and postﬁxed in “1% OsO4”i n
PBS for “1h” at room temperature. The cell pellets were
embedded in “2%” agar, thoroughly rinsed with S¨ orensen
buﬀer (“pH 7.2”) and dehydrated in ethanol. Finally, the
p e l l e t sw e r ee m b e d d e di nE p o nr e s i na n dp o l y m e r i z e da t
“60◦C” for “24h.” Ultrathin sections were stained with
uranyl acetate and lead citrate and observed under a Zeiss
EM900 transmission electron microscope.
2.5. Double Immunocytochemical Detection of Lysosomes
Proteins and Mitochondria. Cells were incubated with a
solution of antilysosomes proteins (autoimmune serum
recognizing the lysosome proteins, a kind gift of the IRCCS
San Matteo, Pavia, Italy) diluted “1:500” in PBS and another
primary antibody: mitochondrial anti-HSP70 (Molecular
Probes, Invitrogen) diluted “1:50” in PBS. After “60min”
at room temperature, coverslips were incubated with the
secondary antibody: Alexa 594-conjugated anti-human anti-
body (Molecular Probes, Invitrogen) diluted “1:200” in PBS
for lysosome proteins and Alexa 488-coniugated anti-mouse
for HSP70 for “1h.” Sections were counterstained for DNA
with “0.1μg/mL” Hoechst “33258”, washed with PBS, and
mounted in a drop of Mowiol (Calbiochem), for confocal
microscopy analysis. Three independent experiments were
carried out. Confocal microscope software was used to
obtain bar charts of colocalization; eight ﬁelds of cells were
considered to count number of lysosomes per cells, both in
controlandin treatedsample,andthegraphic wasdone with
excel program.
2.6. Confocal Fluorescence Microscopy. For confocal laser
scanning microscopy, Leica TCS-SP system (Leica, Heidel-
berg, Germany) mounted on a Leica DMIRBE-inverted
microscope was used. For ﬂuorescence excitation, an Ar/UV
laser at “364nm” was used for Hoechst “33258”, an Ar/Vis
laser at “488nm” was used for FITC, and an He/Ne laser
at “543nm” was used for Alexa 594. Spaced (“0.5μm”)
optical sections were recorded using a “63×” oil immersion
objective. Images were collected in the “1024 × 1024pixel”
format, stored on a magnetic mass memory and processed
by Leica confocal software.
3. Results
Our experiments revealed that cisPt treatment entails an
organellar degradation and a reorganization in the cyto-
plasm. In particular, Golgi apparatus, endoplasmic reticu-
lum, and lysosomes are the main target of the drug.
Figure 1 shows the Golgi apparatus (green ﬂuorescence)
in control cells (a) and in 48h cisPt-treated cells (b); in
control cells, Golgi exhibits its typical shape “ribbon like,”
with ﬂattened cisternae, according to its function as a
proteins sorter. It mostly has a perinuclear localization in
the cytoplasm with a progressive decreased concentration
towards the periphery of the cell. In cisPt treated cells, a
strong production of vesicles is visible, accompanied by a
spatial redistribution and dense masses. After treatment, the
tubulincytoskeleton(redﬂuorescence)showsmorphological
changes, too. Soldani et al. [15] demonstrated that the
morphological alterations of the Golgi apparatus may beInternational Journal of Cell Biology 3
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Figure 1: Double immunolabeling of Golgi apparatus (green ﬂuorescence) and α-tubulin (red ﬂuorescence) in B50 control cells (a) and in
48h cisPt-treated cells (b). In (b), arrow indicates an apoptotic cell. DNA is counterstained with Hoechst 33258 (blue ﬂuorescence). Bar:
20μm.
(a) (b) (c)
(a )( b  )( c  )
Figure 2: Double immunolabeling of Golgi apparatus (green ﬂuorescence) and endoplasmic reticulum (red ﬂuorescence) in B50 control
cells(a,b,andc)andin48hcisPt-treatedcells(a ,b  ,andc ).In(c)and(c ),DNAiscounterstainedwithHoechst33258(blueﬂuorescence).
Bar: 20μm.
related to structural changes in cytoskeletal apparatus [15];
in the treated cells, in fact, it can be observed that the
vesiculation of this organelle is localized mainly at the
periphery of the cell (arrow).
It is well known that the endoplasmic reticulum and
Golgi apparatus are closely linked in terms of both orga-
nizational and functional point of view in the process
of synthesis and posttranslational maturation of proteins
through an intense vesicular traﬃc. In Figure 2, the double
immunoexpression of Golgi apparatus and endoplasmic
reticulum is shown both in control cells (a, b, and c) and
in treated cells (a ,b  ,a n dc  ). In the ﬁrst condition, Golgi
apparatus maintains the perinuclear location (a) as it is
above described in Figure 1, and endoplasmic reticulum is
homogeneously arranged in the whole cytoplasm (b), where
it is main concentrated near the nucleus. In the second4 International Journal of Cell Biology
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Figure 3: Cellular morphology at TEM in B50 control cells (a and b) and in 48h cisPt-treated cells (a  and b ). In (a and a ), asterisks
indicatesendoplasmic reticulum; in (a ), stars indicate damaged mitochondria. In (b and b ), arrows indicate Golgi apparatus. Bar: 6μm.
condition, Golgi apparatus undergoes a strong disruption
losing the typical semilunar shape (a ), while endoplasmic
reticulum is less thickened and quite disrupted, too (b ).
Figure 3 depicts the ultrastructural morphology of B50
control (a and b) and treated (a  and b )c e l l sa tT E M .I n
(a) it is visible a cellular area with the intact endoplasmic
reticulum (asterisks) properly distributed in the cytoplasm,
but after treatment (a ) it results heavily dilated (asterisks).
In (a )itisalsoappreciablethemitochondrialdamage(stars)
cisPt induced [12]. In (b) Golgi apparatus in physiological
condition is shown (arrow), but after treatment (b ) it results
suﬀering,becauseitlosestheregularshapeofcisternaewhich
becomes in some case dilated and in other more thickened
(arrows).
Lysosomes are cisPt target, too. In Figure 4 the double
immunolabeling of lysosomes (red ﬂuorescence) and mito-
chondria (green ﬂuorescence) is reported, compared to a
c o n t r o ls i t u a t i o n( a ) ,w h e r el y s o s o m e sa r en u m e r o u s ,a n d
mitochondriapresentstheirtypicalcytoplasmicdistribution,
after cisPt injury (b) cells show a decrease of lysosomes
number (c: from 83 ± 20.44 to 50.5 ± 6.99; a reduction
of about 30%) and mitochondria form dense perinuclear
masses (b: triangle). Moreover, it has to be noted that
lysosomal and mitochondrial expressions do not colocalized
in treated cells (see bar charts of colocalization b  and b   for
the selected point of noncolocalization asterisk in b).
4. Discussion
It is generally accepted that the damage induced upon
binding of cisPt with the DNA may inhibit transcription
and/or DNA replication mechanisms [16]. The process of
cisplatin-induced apoptosis is complex and involves multiple
pathways [2, 12], and in literature several studies demon-
stratethatapoptosis induced bycisPt canalsobe DNA injury
independent [17]. Nevertheless, in cisPt-induced cell death
mitochondrial are considered perhaps a more important
target than nuclear DNA damage [18], due to hydrolyzed
cisPt that generates a positively charged metabolite which
preferentially accumulates within the negatively charged
mitochondria. Thus, the sensitivity of cells to cisplatin
appears to correlate with both the density of mitochondria
[19] and the mitochondrial membrane potential [20]. We
have already demonstrated that cisPt targets, in addition
to DNA, included the cytoskeleton (actin and tubulin) and
mitochondria [12]. Recent data have shown that cisPt is able
toinducecelldeathindiﬀerentcelllinesandthatthisimplies
the involvement of cytoplasmic organelles [11]. In addition,International Journal of Cell Biology 5
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Figure 4: Double immunolabeling of lysosomes (red ﬂuorescence) and mitochondria (green ﬂuorescence) in B50 control cells (a) and in
48hcisPt-treatedcells(b).DNAiscounterstainedwithHoechst33258(blueﬂuorescence).Bar:20μm.In(c),barchartoflysosomesnumber
per cells (average). In b, triangle represents dense mitochondrial masses, asterisk represents the selected point of noncolocalization. In (b ,
b  ), bar charts of colocalization, the (b ) bar chart is for red ﬂuorescence, the (b  ) is for green ﬂuorescence.6 International Journal of Cell Biology
Nakagomi et al. [21] have identiﬁed the fragmentation
of the Golgi apparatus during apoptosis as a marker of
some neurodegenerative diseases [21]. The results obtained
have allowed us to demonstrate the onset of organelles
alterations after cisPt treatment in B50 neuroblastoma rat
cells. In particular, we focused on Golgi apparatus and
endoplasmic reticulum injury, organelles that make up the
digestive vacuole of the cell [7]. Both of them have been
called “stress sensor” as it has been shown that proteins on
their membranes are able to trigger the caspase cascade by
activating caspase-12 [2, 6, 8]. Our obtained results, both
in confocal microscopy and in TEM, indicate that these
organelles undergo strong rearrangement due to the 48h
cisPt treatment and that these alterations are linked to the
reorganizationofcytoskeletaltubulin.Thisevidencesuggests
that the whole process is also on the base of the generation of
apoptotic bodies, designed for the ultimate phagocytosis.
Theeﬀectof cisPt has been also evident in lysosomes that
become smaller and less numerous in treated cells. Because
lysosomes are involved also in autophagy mechanisms,
we applied a double immunolabeling of lysosomes and
mitochondria in order to analyze if therewasa colocalization
between the two respective ﬂuorescence. The absence of this
colocalization after 48h treatment indicates that cisPt does
not induce any autophagic process as alternative response
to the treatment. So, we can conclude that immunocyto-
chemical techniques and the TEM are useful to demonstrate
that B50 neuroblastoma cells undergo apoptosis through
organelles injury, and not only as a consequent of DNA
damage.
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